Patents by Inventor Thomas Kryzer

Thomas Kryzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Autoantibodies to Septin-7 and diagnosis of neurological disease
    Patent number: 11835519
    Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: December 5, 2023
    Assignees: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and Research
    Inventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat
  • Diagnosis of a neurological disease
    Publication number: 20210181196
    Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 17, 2021
    Applicants: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and Research
    Inventors: Ramona MISKE, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat
  • Marker for neuromyelitis optica
    Publication number: 20050112116
    Abstract: The present invention provides for methods and materials for diagnosing and treating neuromyelitis optica (NMO).
    Type: Application
    Filed: November 25, 2003
    Publication date: May 26, 2005
    Inventors: Vanda Lennon, Thomas Kryzer
  • Immunoassay for small cell lung carcinoma
    Patent number: 5256540
    Abstract: An immunoassay for small cell lung carcinoma is provided which uses small cell lung carcinoma voltage-gated calcium channel antigen (SCC-VGCC Ag) comprising a detectable label and antibodies against SCC-VGCC Ag to detect endogenous SCC-VGCC Ag.
    Type: Grant
    Filed: December 28, 1990
    Date of Patent: October 26, 1993
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Vanda A. Lennon, Edward H. Lambert, Thomas Kryzer, Guy E. Griesmann